<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39449087</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>25</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2200-6133</ISSN><JournalIssue CitedMedium="Print"><Volume>16</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>25</Day></PubDate></JournalIssue><Title>Pneumonia (Nathan Qld.)</Title><ISOAbbreviation>Pneumonia (Nathan)</ISOAbbreviation></Journal><ArticleTitle>Effect of the Covid-19 pandemic on hospitalizations for non-Covid-19-pneumonia and exacerbations of chronic obstructive pulmonary diseases in Switzerland: comparison of national data between 2020/2021 and 2015-2019.</ArticleTitle><Pagination><StartPage>24</StartPage><MedlinePgn>24</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1186/s41479-024-00150-y</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Protective measures applied during the Covid-19 pandemic had a marked impact on the incidence of pneumonia. However, systematic data are lacking for hospitalizations for pneumonia and acute exacerbations of chronic obstructive lung diseases (AECOPD) not caused by SARS-CoV-2 in Switzerland. We aimed to compare the incidences of hospitalization for these entities between 2020/2021 and prepandemic years.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This retrospective study examined all nationwide hospitalizations for non-Covid-19-pneumonia and AECOPD listed as primary diagnoses based on ICD-10 codes between 2015 and 2021 in a publicly available hospitalization database of the Swiss Federal Statistical Office. Hospitalizations for acute coronary syndrome (ACS) and stroke were used as controls. Changes of monthly incidences of hospitalizations, length of stay (LOS) and mortality were compared between 2020/2021 and the average of 2015-2019.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The incidences of hospitalizations for AECOPD and for pneumonia showed seasonal variations from 2015 to 2019 followed by significant and almost identical decreases in 2020/2021 (incidence rate ratio [IRR] 0.59, 95% CI: 0.45-0.77, p &lt; 0.001, and IRR: 0.62, 95% CI: 0.52-0.74, p &lt; 0.001, respectively). Hospital-mortality was slightly higher in 2020/2021 for AECOPD (2015-2019: 3.8%; 2020/2021: 4.2%, odds ratio [OR] 1.24, 95% CI: 1.07-1.44, p = 0.004) and for pneumonia (2015-2019: 4.5%, 2020/2021: 4.6%, odds ratio [OR] 1.17, 95% CI: 1.07-1.28, p &lt; 0.001). Median LOS slightly decreased for AECOPD (2015-2019: 8 [IQR: 5-14] days; 2020/2021: 7 [IQR: 4-13] days, Wilcoxon test: p &lt; 0.001) but slightly increased for pneumonia (2015-2019: 7 [IQR: 4-11] days; 2020/2021: 7 [IQR: 4-13] days, Wilcoxon test: p &lt; 0.001). Throughout 2020/2021, there were no significant fluctuations observed in the incidences of ACS and stroke. (IRR: 0.98, 95% CI: 0.83-1.16, p = 0.810, IRR: 0.96, 95% CI: 0.81-1.14, p = 0.636, respectively).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The first two years of the Covid-19 pandemic showed a marked decrease in incidences in AECOPD and non-Covid-19 pneumonia hospitalizations in Switzerland. It is likely that this effect is associated with the society-based, at first vigorous, social distancing measures.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bürke</LastName><ForeName>Carla</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Infection Prevention and Travel Medicine, Cantonal Hospital St. Gallen, University Teaching and Research Hospital, Rorschacherstrasse 95, St. Gallen, CH-9007, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baty</LastName><ForeName>Florent</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Lung Center, Cantonal Hospital St. Gallen, St. Gallen, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rassouli</LastName><ForeName>Frank</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Lung Center, Cantonal Hospital St. Gallen, St. Gallen, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brutsche</LastName><ForeName>Martin H</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Lung Center, Cantonal Hospital St. Gallen, St. Gallen, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Albrich</LastName><ForeName>Werner C</ForeName><Initials>WC</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Infection Prevention and Travel Medicine, Cantonal Hospital St. Gallen, University Teaching and Research Hospital, Rorschacherstrasse 95, St. Gallen, CH-9007, Switzerland. werner.albrich@kssg.ch.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Pneumonia (Nathan)</MedlineTA><NlmUniqueID>101663459</NlmUniqueID><ISSNLinking>2200-6133</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute exacerbations of COPD (AECOPD)</Keyword><Keyword MajorTopicYN="N">COPD</Keyword><Keyword MajorTopicYN="N">Covid-19</Keyword><Keyword MajorTopicYN="N">Covid-19 restrictions</Keyword><Keyword MajorTopicYN="N">Pneumonia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>10</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>6</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>6</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>25</Day><Hour>1</Hour><Minute>10</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39449087</ArticleId><ArticleId IdType="doi">10.1186/s41479-024-00150-y</ArticleId><ArticleId IdType="pii">10.1186/s41479-024-00150-y</ArticleId></ArticleIdList><ReferenceList><Title>References</Title><Reference><Citation>Talic S, Shah S, Wild H, Gasevic D, Maharaj A, Ademi Z, et al. Effectiveness of public health measures in reducing the incidence of covid-19, SARS-CoV-2 transmission, and covid-19 mortality: systematic review and meta-analysis. The BMJ. 2021;375:e068302.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-068302</ArticleId><ArticleId IdType="pubmed">34789505</ArticleId><ArticleId IdType="pmc">9423125</ArticleId></ArticleIdList></Reference><Reference><Citation>Bundesamt für Gesundheit. Der Einfluss der durch COVID-19-bedingten Massnahmen und Verhaltensänderungen auf meldepflichtige Infektionskrankheiten in der Schweiz im Jahr 2020. BAG Bull. 2021;30:8–13.</Citation></Reference><Reference><Citation>Bericht zur Grippesaison 2020/21. BAG-Bull. 2021;45(45). Verfügbar unter: https://www.infovac.ch/docs/public/influenza/bericht-zur-grippesaison-2020-21-.pdf . Zitiert 17 Jul 2022.</Citation></Reference><Reference><Citation>Brueggemann AB, Jansen van Rensburg MJ, Shaw D, McCarthy ND, Jolley KA, Maiden MCJ, et al. Changes in the incidence of invasive disease due to Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis during the COVID-19 pandemic in 26 countries and territories in the invasive respiratory infection surveillance initiative: a prospective analysis of surveillance data. Lancet Digit Health. 2021;3(6):e360-70.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2589-7500(21)00077-7</ArticleId><ArticleId IdType="pubmed">34045002</ArticleId><ArticleId IdType="pmc">8166576</ArticleId></ArticleIdList></Reference><Reference><Citation>Welte T, Torres A, Nathwani D. Clinical and economic burden of community-acquired pneumonia among adults in Europe. Thorax. 2012;67(1):71–9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thx.2009.129502</ArticleId><ArticleId IdType="pubmed">20729232</ArticleId></ArticleIdList></Reference><Reference><Citation>Albrich WC, Rassouli F, Waldeck F, Berger C, Baty F. Influence of Older Age and Other Risk Factors on Pneumonia Hospitalization in Switzerland in the Pneumococcal Vaccine Era. Front Med [Internet]. 2019;6. Verfügbar unter: https://www.frontiersin.org/articles/10.3389/fmed.2019.00286 . Zitiert 28. Nov 2022</Citation></Reference><Reference><Citation>Safiri S, Carson-Chahhoud K, Noori M, Nejadghaderi SA, Sullman MJM, Heris JA, et al. Burden of chronic obstructive pulmonary disease and its attributable risk factors in 204 countries and territories, 1990–2019: results from the global burden of disease study 2019. BMJ. 2022;378:e069679.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-069679</ArticleId><ArticleId IdType="pubmed">35896191</ArticleId><ArticleId IdType="pmc">9326843</ArticleId></ArticleIdList></Reference><Reference><Citation>The top 10 causes of death. Verfügbar unter: https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death . Zitiert 28 Nov 2022.</Citation></Reference><Reference><Citation>Iheanacho I, Zhang S, King D, Rizzo M, Ismaila AS. Economic burden of Chronic Obstructive Pulmonary Disease (COPD): a systematic literature review. Int J Chron Obstruct Pulmon Dis. 2020;15:439–60.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/COPD.S234942</ArticleId><ArticleId IdType="pubmed">32161455</ArticleId><ArticleId IdType="pmc">7049777</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan KPF, Ma TF, Kwok WC, Leung JKC, Chiang KY, Ho JCM, et al. Significant reduction in hospital admissions for acute exacerbation of chronic obstructive pulmonary disease in Hong Kong during coronavirus disease 2019 pandemic. Respir Med. 2020;171:106085.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2020.106085</ArticleId><ArticleId IdType="pubmed">32917356</ArticleId><ArticleId IdType="pmc">7354382</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawless M, Burgess M, Bourke S. Impact of COVID-19 on hospital admissions for COPD exacerbation: lessons for future care. Medicina (Mex). 2022;58(1):66.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina58010066</ArticleId></ArticleIdList></Reference><Reference><Citation>Studer S, Rassouli F, Waldeck F, Brutsche MH, Baty F, Albrich WC. No evidence of harmful effects of steroids in severe exacerbations of COPD associated with influenza. Infection. 2022;50(3):699–707.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-021-01743-1</ArticleId><ArticleId IdType="pubmed">35091985</ArticleId><ArticleId IdType="pmc">8799421</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C. The COVID-19 Pandemic and the incidence of the Non-COVID-19 pneumonia in adults. Front Med. 2021;8:737999.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.737999</ArticleId></ArticleIdList></Reference><Reference><Citation>Saeed MI, Sivapalan P, Eklöf J, Ulrik CS, Browatzki A, Weinreich UM, et al. Social distancing in relation to severe exacerbations of chronic obstructive pulmonary disease: a nationwide semi-experimental study during the COVID-19 pandemic. Am J Epidemiol. 2022;191(5):874–85.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwab292</ArticleId><ArticleId IdType="pubmed">34999742</ArticleId></ArticleIdList></Reference><Reference><Citation>How has the pandemic affected people’s help-seeking behaviour and attitudes? Cancer Research UK. 2021. Verfügbar unter: https://www.cancerresearchuk.org/health-professional/health-professional-news/how-has-the-pandemic-affected-peoples-help-seeking-behaviour-and-attitudes . Zitiert 25 Jan 2023.</Citation></Reference><Reference><Citation>Rosenbaum L. The untold toll — The pandemic’s effects on patients without Covid-19. N Engl J Med. 2020;382(24):2368–71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMms2009984</ArticleId><ArticleId IdType="pubmed">32302076</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandell LA. Community-acquired pneumonia: an overview. Postgrad Med. 2015;127(6):607–15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00325481.2015.1074030</ArticleId><ArticleId IdType="pubmed">26224210</ArticleId><ArticleId IdType="pmc">7103686</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko FW, Chan KP, Hui DS, Goddard JR, Shaw JG, Reid DW, et al. Acute exacerbation of COPD. Respirology. 2016;21(7):1152–65.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/resp.12780</ArticleId><ArticleId IdType="pubmed">27028990</ArticleId><ArticleId IdType="pmc">7169165</ArticleId></ArticleIdList></Reference><Reference><Citation>Domenech A, Puig C, Martí S, Santos S, Fernández A, Calatayud L, et al. Infectious etiology of acute exacerbations in severe COPD patients. J Infect. 2013;67(6):516–23.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2013.09.003</ArticleId><ArticleId IdType="pubmed">24055804</ArticleId></ArticleIdList></Reference><Reference><Citation>Christenson SA, Smith BM, Bafadhel M, Putcha N. Chronic obstructive pulmonary disease. Lancet. 2022;399(10342):2227–42.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00470-6</ArticleId><ArticleId IdType="pubmed">35533707</ArticleId></ArticleIdList></Reference><Reference><Citation>Ritchie AI, Wedzicha JA. Definition, causes, pathogenesis, and consequences of chronic obstructive pulmonary disease exacerbations. Clin Chest Med. 2020;41(3):421–38.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccm.2020.06.007</ArticleId><ArticleId IdType="pubmed">32800196</ArticleId><ArticleId IdType="pmc">7423341</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabatabaeizadeh SA. Airborne transmission of COVID-19 and the role of face mask to prevent it: a systematic review and meta-analysis. Eur J Med Res. 2021;26(1):1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40001-020-00475-6</ArticleId><ArticleId IdType="pubmed">33388089</ArticleId><ArticleId IdType="pmc">7776300</ArticleId></ArticleIdList></Reference><Reference><Citation>Zotero | Your personal research assistant. Verfügbar unter: https://www.zotero.org/ . Zitiert 19 Mai 2023.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>